Personalization of CAR-T cell products using biomaterials. (IMAGE)
Caption
A new study performed in collaboration by David Mooney’s team at the Wyss Institute and Harvard SEAS and Catherine Wu’s team at the DFCI used these artificial antigen-presenting cell-mimicking scaffolds (APC-ms) to create personalized CAR-T cell products from patients’ T cells.
Credit
Wyss institute at Harvard University
Usage Restrictions
None
License
Original content